Rallybio Corporation Announces Pricing of Initial Public Offering
NEW HAVEN, Conn.–(BUSINESS WIRE)–#Rallybio–Rallybio Corporation (Rallybio), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced the […]